SOPHiA GENETICS (SOPH:LSE) Investor Relations Material

Overview

Switzerland-based company, SOPHiA GENETICS SA, is a prominent player in the healthcare industry with its cloud-native software technology solutions. Their flagship offering is the SOPHiA DDM platform, which harnesses the power of multimodal data sets and diagnostic modalities to generate valuable insights. The company's innovative platform has garnered attention from a global clientele, including hospitals, laboratories, and biopharma customers. Since its establishment in 2011, SOPHiA GENETICS SA has been dedicated to revolutionizing the healthcare industry, with its headquarters located in Saint-Sulpice.

Frequently Asked Questions

What is SOPHiA GENETICS's ticker?

SOPHiA GENETICS's ticker is SOPH

What exchange is SOPHiA GENETICS traded on?

The company's shares trade on the LSE stock exchange

Where are SOPHiA GENETICS's headquarters?

They are based in Oxford, England

How many employees does SOPHiA GENETICS have?

There are 1001-5000 employees working at SOPHiA GENETICS

What is SOPHiA GENETICS's website?

It is sophiagenetics.com

What type of sector is SOPHiA GENETICS?

SOPHiA GENETICS is in the Technology sector

What type of industry is SOPHiA GENETICS?

SOPHiA GENETICS is in the Security Software & Services industry

Who are SOPHiA GENETICS's peers and competitors?

The following five companies are SOPHiA GENETICS's industry peers:

- ManTech International

- Applied DNA Sciences

- SOPHiA GENETICS

- Intrusion